IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2022 Holdings

Filed 2022-08-16 | 14 holdings | $24.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$23.9M117,24898.8%
United Therapeutics Corp(UTHR)COM91307C102$47.4K201,2280.2%
Alkermes PLC(ALKS)COMG01767105$41.7K1,398,1590.2%
Regeneron Pharmaceuticals(REGN)COM75886F107$35.7K60,3840.1%
Exelixis Inc(EXEL)COM30161Q104$31.4K1,506,8850.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$29.5K624,7680.1%
Mckesson Corp(MCK)COM58155Q103$27.0K82,8940.1%
Embecta Corp(EMBC)COM29082K105$25.8K1,017,1940.1%
Taro Pharmaceutical IndusCOMM8737E108$21.0K580,5240.1%
Cardinal Health Inc(CAH)COM14149Y108$9.3K178,8390.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$5.4K121,0140.0%
Kodiak Sciences Inc(KOD)COM50015M109$4.2K554,1920.0%
Nextcure IncCOM65343E108$14630,9990.0%
Assembly Biosciences IncCOM045396108$219,9850.0%